170 related articles for article (PubMed ID: 26208133)
1. Targeted delivery of doxorubicin and vincristine to lymph cancer: evaluation of novel nanostructured lipid carriers in vitro and in vivo.
Dong X; Wang W; Qu H; Han D; Zheng J; Sun G
Drug Deliv; 2016 May; 23(4):1374-8. PubMed ID: 26208133
[TBL] [Abstract][Full Text] [Related]
2. Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers.
Ni S; Qiu L; Zhang G; Zhou H; Han Y
Int J Nanomedicine; 2017; 12():1565-1576. PubMed ID: 28280326
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy.
Liu Q; Li J; Pu G; Zhang F; Liu H; Zhang Y
Drug Deliv; 2016 May; 23(4):1364-8. PubMed ID: 25874959
[TBL] [Abstract][Full Text] [Related]
4. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-coated cationic nanostructured lipid carriers for oral vincristine sulfate delivery.
Gao X; Zhang J; Xu Q; Huang Z; Wang Y; Shen Q
Drug Dev Ind Pharm; 2017 Apr; 43(4):661-667. PubMed ID: 28043185
[TBL] [Abstract][Full Text] [Related]
6. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers.
Cao C; Wang Q; Liu Y
Drug Des Devel Ther; 2019; 13():1087-1098. PubMed ID: 31118562
[No Abstract] [Full Text] [Related]
8. Biotin anchored nanostructured lipid carriers for targeted delivery of doxorubicin in management of mammary gland carcinoma through regulation of apoptotic modulator.
Tripathi CB; Parashar P; Arya M; Singh M; Kanoujia J; Kaithwas G; Saraf SA
J Liposome Res; 2020 Mar; 30(1):21-36. PubMed ID: 30741049
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect.
Wang Y; Zhang H; Hao J; Li B; Li M; Xiuwen W
Drug Deliv; 2016 May; 23(4):1398-403. PubMed ID: 26079530
[TBL] [Abstract][Full Text] [Related]
10. Design of smart chemotherapy of doxorubicin hydrochloride using nanostructured lipid carriers and solid lipid nanoparticles for improved anticancer efficacy.
Yeo S; Wu H; Yoon I; Lee WK; Hwang SJ
Int J Pharm; 2024 May; 657():124048. PubMed ID: 38537925
[TBL] [Abstract][Full Text] [Related]
11. Nanocarrier-Based Combination Chemotherapy for Resistant Tumor: Development, Characterization, and Ex Vivo Cytotoxicity Assessment.
Raikwar S; Vyas S; Sharma R; Mody N; Dubey S; Vyas SP
AAPS PharmSciTech; 2018 Nov; 19(8):3839-3849. PubMed ID: 30280350
[TBL] [Abstract][Full Text] [Related]
12. Combined photothermal-chemotherapy of breast cancer by near infrared light responsive hyaluronic acid-decorated nanostructured lipid carriers.
Zheng S; Nguyen VD; Song SY; Han J; Park JO
Nanotechnology; 2017 Oct; 28(43):435102. PubMed ID: 28783035
[TBL] [Abstract][Full Text] [Related]
13. Reversal of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR by LY980503.
Wu DL; Xu Y; Yin LX; Lu HZ
World J Gastroenterol; 2007 Apr; 13(15):2234-7. PubMed ID: 17465508
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody.
Abdolahpour S; Toliyat T; Omidfar K; Modjtahedi H; Wong AJ; Rasaee MJ; Kashanian S; Paknejad M
Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):89-94. PubMed ID: 28296511
[TBL] [Abstract][Full Text] [Related]
15. Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy.
Li X; Jia X; Niu H
Int J Nanomedicine; 2018; 13():4107-4119. PubMed ID: 30034236
[TBL] [Abstract][Full Text] [Related]
16. Bacterial cellulose hydrogel loaded with lipid nanoparticles for localized cancer treatment.
Cacicedo ML; Islan GA; León IE; Álvarez VA; Chourpa I; Allard-Vannier E; García-Aranda N; Díaz-Riascos ZV; Fernández Y; Schwartz S; Abasolo I; Castro GR
Colloids Surf B Biointerfaces; 2018 Oct; 170():596-608. PubMed ID: 29975908
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin- and cisplatin-loaded nanostructured lipid carriers for breast cancer combination chemotherapy.
Di H; Wu H; Gao Y; Li W; Zou D; Dong C
Drug Dev Ind Pharm; 2016 Dec; 42(12):2038-2043. PubMed ID: 27184819
[TBL] [Abstract][Full Text] [Related]
18. Novel decorated nanostructured lipid carrier for simultaneous active targeting of three anti-cancer agents.
Mahoutforoush A; Solouk A; Hamishehkar H; Haghbin Nazarpak M; Abbaspour-Ravasjani S
Life Sci; 2021 Aug; 279():119576. PubMed ID: 33965376
[TBL] [Abstract][Full Text] [Related]
19. Etoposide-loaded nanostructured lipid carriers for gastric cancer therapy.
Jiang H; Pei L; Liu N; Li J; Li Z; Zhang S
Drug Deliv; 2016 May; 23(4):1379-82. PubMed ID: 26162024
[TBL] [Abstract][Full Text] [Related]
20. Improved pharmacokinetics and enhanced tumor growth inhibition using a nanostructured lipid carrier loaded with doxorubicin and modified with a layer-by-layer polyelectrolyte coating.
Mussi SV; Parekh G; Pattekari P; Levchenko T; Lvov Y; Ferreira LAM; Torchilin VP
Int J Pharm; 2015 Nov; 495(1):186-193. PubMed ID: 26325314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]